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Abstract
The dual role of glycolytic enzymes in cytosol-located metabolic processes and in cell
surface-mediated functions with an influence on virulence is described for various micro-
organisms. Cell wall-less bacteria of the classMollicutes including the common human
pathogenMycoplasma pneumoniae possess a reduced genome limiting the repertoire of
virulence factors and metabolic pathways. After the initial contact of bacteria with cells of
the respiratory epithelium via a specialized complex of adhesins and release of cell-
damaging factors, surface-displayed glycolytic enzymes may facilitate the further interac-
tion between host and microbe. In this study, we described detection of the four subunits of
pyruvate dehydrogenase complex (PDHA-D) among the cytosolic and membrane-
associated proteins ofM. pneumoniae. Subunits of PDH were cloned, expressed and puri-
fied to produce specific polyclonal guinea pig antisera. Using colony blotting, fractionation
of total proteins and immunofluorescence experiments, the surface localization of PDHA-C
was demonstrated. All recombinant PDH subunits are able to bind to HeLa cells and human
plasminogen. These interactions can be specifically blocked by the corresponding polyclon-
al antisera. In addition, an influence of ionic interactions on PDHC-binding to plasminogen
as well as of lysine residues on the association of PDHA-D with plasminogen was con-
firmed. The PDHB subunit was shown to activate plasminogen and the PDHB-plasminogen
complex induces degradation of human fibrinogen. Hence, our data indicate that the
surface-associated PDH subunits might play a role in the pathogenesis ofM. pneumoniae
infections by interaction with human plasminogen.
Introduction
The cell wall-less micro-organismMycoplasma pneumoniae is an agent of atypical pneumo-
nia in humans. Infections are most common in children and young adults, but all age groups
can be affected. Up to nearly 30% of cases of community-acquired pneumonia are caused by
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this bacterium [1, 2]. Small-scale outbreaks have been mainly described in populations with
close contact such as schools, colleges and army camps. In contrast, nation-wide or even
world-wide peaks in the incidence of infections due toM. pneumoniae are reported every 3 to
7 years [1, 3].
With a genome size of 816 kbp and 688 open reading framesM. pneumoniae is one of the
smallest self-replicating organisms known [4]. The limited genomic resources reduce the reper-
toire of metabolic pathways as well as of virulence factors. In consequence, these bacteria de-
pend greatly on the host for successful in vivo replication. As a first step in colonization, the
mycoplasmas adhere to the human respiratory mucosa, which is mediated by the attachment
organelle, a unusual tip structure of theM. pneumoniae cell comprising a complex of adhesins
and adherence-associated proteins [5]. The further infection process is associated with the re-
lease of hydrogen peroxide, superoxide anions [6–7] and the pertussis-like CARDS toxin [8]
which results in interference with the integrity of the respiratory epithelium.
Because of the reduced genome,M. pneumoniae lacks the citric acid cycle and glycolysis is
the major pathway to produce adenosine triphosphate (ATP). Despite the fact that this process
takes place in the cytosol of the cells, glycolytic enzymes can be transported by an unknown
mechanism to the surface of the microorganisms [9], where they may interact with host fac-
tors. First reported for streptococci, this phenomenon seems a common feature as it is de-
scribed in phylogenetically different organisms including gram-negative and -positive
bacteria, fungi and parasites [10–12]. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and enolase of various organisms are typical examples for surface-displayed glycolytic en-
zymes that interact with proteins of the human extracellular matrix (ECM). The number of
host ECM components which are described as binding partners of microbial glycolytic en-
zymes has increased in recent years [12–14]. Since these interactions are known in different
pathogenic microorganisms, a general role in host-microbe interaction and also as virulence
factor cannot be excluded.
Surface localization of glycolytic enzymes and their interaction with host components
were also described for different mycoplasma species [15–19]. InM. pneumoniae, the E1β
subunit of pyruvate dehydrogenase (PDHB) is able to interact with human fibronectin [20]
and with human plasminogen [21]. Furthermore, GAPDH was characterized as binding part-
ner of human fibrinogen [22]. However, analysis of the Triton X (TX)-100 insoluble proteins
of total cells indicates that further glycolytic enzymes can be found in the fraction of mem-
brane-associated proteins ofM. pneumoniae [23] including subunit A of the PDH complex.
In addition, this subunit is known to be a protein which is complexed to the P1 protein [24],
the major adhesin ofM. pneumoniae. These aspects suggest that, besides PDHB, further
PDH subunits can be cell surface-exposed and, in consequence, can function as possible in-
teraction partners of human ECM proteins. The PDH complex consists of four enzymatic
components: pyruvate dehydrogenase major (E1α; PDHA) and minor (E1β) subunits, dihy-
drolipoyl acetyltransferase (E2; PDHC) and dihydrolipoyl dehydrogenase (E3; PDHD). The
components are encoded by the genes pdhA (mpn393), pdhB (mpn392), pdhC (mpn391) and
pdhD (mpn390) [4]. These are organized in two operons encoding for the E1α and E1β sub-
units and the other for the E2 and E3 subunits ([25]; http://csbl.bmb.uga.edu/DOOR/, http://
operons.ibt.unam.mx/OperonPredictor/).
In the present study, subunits of the PDH complex ofM. pneumoniae were characterized as
cluster of plasminogen-binding proteins which are displayed on the surface of the cell. Further-
more, PDHB was able to activate plasminogen and the complex degrades human fibrinogen.
The data contribute to the understanding of the infection process due to an important human
pathogen with a minimal genome.
Characterization of PDH Cluster ofMycoplasma pneumoniae
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Material and Methods
Bacteria, cell line and growth conditions
TheM. pneumoniae strain M129 (ATCC 29342), the Escherichia coli strains NovaBlue (Nova-
gen, Darmstadt, Germany, #70181–3) and BL21(DE3) (Novagen, #70235), and the HeLa cells
(human cervical carcinoma cell line, ATCC CCL-2) were grown as described [21, 22]. Protein
concentration of cells was measured with the BCA protein assay kit (Pierce, Rockford, IL, USA,
#23227) as recommended by the manufacturer.
Expression and purification of recombinant proteins
DNA was isolated fromM. pneumoniae using the QIAamp DNA mini kit (Qiagen, Limburg,
Netherlands, #51304) as described by the manufacturer (blood and fluid protocol). PCR with
primers (Table 1) amplified the genome region surrounding the genes coding for PDHA-D.
The products of the PCR were purified with the QIAquick PCR purification kit (Qiagen,
Table 1. Oligonucleotides used in the study (underlined: vector-specific sequence; double underlined: mutation of TGA to TGG).
Target Oligonucleotide Sequence (5‘- 3‘) Description
PDHA (mpn393) MpPDHAf1 GTT AGC AGC CGT GTT GCA AG Amplification and sequencing
MpPDHAf2 CAA CGA ACA GTT AAA GCA CGC
MpPDHAf3 CAA AAC GCT GCC CAT TAA C
MpPDHAf4 GCG AGT TAC GAA GCA ATG C
MpPDHAr GAT AGA TCC ATT GCG TTA CCC
PDHB (mpn392) MpPDHBf1 GTT GAC TCC TGA TCT AGC GC
MpPDHBf2 CAT GCC AAT GGG TGG TG
MpPDHBf3 GGG TAA CGC AAT GGA TCT AG
MpPDHBf4 GGA CAA GGG CAT TGA ACT C
MpPDHBr CTA GGT GCA ATT ATT CTA ACA AAC
PDHC(mpn391) MpPDHCf CAG CTA ACT GCA GTA AAT GCA AC
MpPDHCr CAC ACG CCA CCA AAG TAT TC
PDHD(mpn390) MpPDHDf1 CAT GGA AGA ACG TGT TGT GC
MpPDHDf2 CAA GAT TGT CGA TTA CCT CC
MpPDHDr CTT CTA ACG CTG CGT TGA AG
PDHA (mpn393) MpPDHAVf GAC GAC GAC AAG ATG GCA ATT TTG ATT AAA AAC MMR* and transformation
MpPDHAM1 P- GCT TGT TTG GCA ACG TGC TG
MpPDHAM2 P- GCT TTT ACT TTA CTG GAA CGG TAA C
MpPDHAM3 P- CCA TTC ACA AGT GGA ACT CGG
MpPDHAM4 P- CTT CTC TTG GCG TCA AGG TC
MpPDHAVr GAG GAG AAG CCC GGT TTA GTC TTT AAA GTA TTT TTT AGC
PDHB (mpn392) MpPDHBVf GAC GAC GAC AAG ATG TCA AAA ACA ATT CAA GCA AAT AAC
MpPDHBM P-CGT ACC ATT TCC CCT TGG GAC AAG
MpPDHBVr GAG GAG AAG CCC GGT TTA CTT TAA AAG TTG GTT AAC AGC TTC
PDHC(mpn391) MpPDHCVf GAC GAC GAC AAG ATG GCA AAT GAG TTT AAG TTC AC
MpPDHCVr GAG GAG AAG CCC GGT CTA AGC TAC TTC TAA ATC AAT TAA TTC
PDHD(mpn390) MpPDHDVf GAC GAC GAC AAG ATG AAT TAC GAT CTC ATT ATT ATA G
MpPDHDM P-GTA GCA CTT ACC TGG AAC CAA TTG
MpPDHDVr GAG GAG AAG CCC GGT CTA TTT AAA GTG ATC AAA AAG AGC
* Multiple Mutation Reaction [26]
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#28104) and served as target for the multiple mutation reaction (MMR; [26]) to change the
TGA codons to TGG during the amplification of the complete genes. Cloning into the pET-30/
LIC vector (Novagen, #69077–3), transformation of E. coli strains NovaBlue and BL21(DE3),
sequencing of inserts, expression, purification and concentration of the N-terminal 6x His-
tagged recombinant proteins were performed as reported recently [21]. Protein concentration
was measured as described.
Production of polyclonal antisera
Anesthetized guinea pigs (Charles River, Sulzfeld, Germany) were used for immunization. Ani-
mal experiments were carried out in accordance with the recommendations of the Federation
of Laboratory Animal Science Associations (FELASA) and approved by the ethical board of
Landesdirektion Sachsen, Dresden, Germany (permit no. 24–9168.25-1/2011-1). Primary sub-
cutaneous immunization of guinea pigs with totalM. pneumoniae antigen and recombinant
proteins rPDHA-D, booster immunizations and sera collection were done as reported [21].
SDS-PAGE, Western Blotting and ELISA
The result of expression of recombinant proteins rPDHA-D was analyzed by SDS-PAGE using
10% NuPage Bis-Tris gels (Life, Darmstadt, Germany, #NPO303 Box) followed by Coomassie
staining (Merck, # 115444). To confirm the specificity of the produced polyclonal antisera,
blottedM. pneumoniae whole cells were incubated with the antisera to rPDHA-D (1:500) and
detected with anti-guinea pig IgG (1:750; Dako, Hamburg, Germany, #P01402-2). Chemilumi-
nescence signals were digitally recorded using a LAS-300 imager (Fujifilm, Düsseldorf,
Germany).
To compare the quantitative reactivity of sera by ELISA, cavities of 96-well plates (Greiner,
#655001) were coated overnight withM. pneumoniae total proteins (15 μg/ml) and blocked as
described [21]. Wells were incubated with guinea pig sera to whole proteins ofM. pneumoniae
and to subunits of the PDH complex (1:250) followed by anti-guinea pig IgG (1:750). After in-
cubation with the substrate (TMB super slow, Sigma, #T5569), the reaction was stopped with
1M HCl and absorbance was detected at 450 nm with reference wavelength of 620 nm.
Fractionation ofM. pneumoniae total proteins
For the localization of proteins PDHA-D in the mycoplasma cell, the total proteins of freshly
grownM. pneumoniae cells were separated into membrane and cytosol fractions by ultracentri-
fugation as described [21]. To control the performance of fractionation in ELISA experiments,
plate wells were coated with the cytosolic and membrane fraction ofM. pneumoniae total pro-
teins (15 μg/ml). Detection was performed with guinea pig sera against the subunits of the
PDH complex (1:250) followed by anti-guinea pig IgG (1:750). The serum to the conserved
surface-exposed C-terminal part of the main P1 adhesin (rP12, [27]) served as control for a
membrane-associated protein. Based on the extensive characterization of this protein [21],
enolase was used as control for a cytosolic and not surface-exposed protein ofM. pneumoniae.
Surface localization of subunits of the PDH complex
Identification of cellular localization of PDHA-D is fundamental for further conclusions about
the role of these proteins in pathogenesis and was studied with different experimental ap-
proaches. For fluorescence microscopy, freshly grownM. pneumoniae cells were inoculated in
cavities of a chamber slide (Thermo, #154526) and treated as reported [21]. For parallel detec-
tion of surface structures of fixed mycoplasma cells, mixtures of guinea pig antibodies to the
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subunits of the PDH complex with rabbit antiserum to the TX-100 insoluble fraction ofM.
pneumoniae total proteins (1:250 each) were added to the cavities. Guinea pig pre-immune
serum and guinea pig antiserum obtained after three subcutaneous immunizations withM.
pneumoniae total proteins (1:250) in combination with a rabbit antiserum to the TX-100 insol-
uble fraction were used as negative and positive controls, respectively. Detection was carried
out with a mixture of FITC-labeled anti-guinea pig IgG (Sigma, #F6261) and TRITC-labeled
anti-rabbit IgG (Sigma, #T6778, 1:500 each). Immunofluorescence of cells was checked at 400x
with a fluorescence microscope (Axioskop, Zeiss, Jena).
The colony blot technique was used to detect the occurrence of PDH subunits on the surface
of the bacteria [21]. Pieces of nitrocellulose with blotted proteins were treated with guinea pig
antisera (1:250 each) to rPDHA-D, to total proteins ofM. pneumoniae (positive control), toM.
pneumoniae enolase and a pre-immune serum (both as negative controls). Detection was car-
ried out as described by using peroxidase-conjugated anti-guinea pig IgG (1:750).
To further assess surface-localized regions of the proteins PDHA-D, mild proteolysis ofM.
pneumoniae cells with trypsin (Sigma, #T1426) was carried out. Pre-examination of cleavage
frequency of proteins analyzed (http://web.expasy.org/peptide_cutter/) resulted in numbers of
cleavage sites of 13 (C-terminal part of P1 adhesin), 32 (PDHB), 37 (PDHC), 40 (PDHA),
44 (PDHD) and 46 (enolase), respectively. Trypsin treatment of cells was done as reported
[21]. In parallel, recombinant proteins enolase and PDHD were treated to confirm digestibility.
Blotted trypsin-treated and untreated proteins were incubated with the antisera to recombinant
proteins rPDHA-D (1:250 each) and sera against enolase and the C-terminal part of P1 protein
ofM. pneumoniae as controls. Anti-guinea pig IgG (1:750) was used for detection.
Binding of recombinant proteins to HeLa cells
Wells of ELISA plates were coated for 2 hours at 37°C with freshly harvested HeLa cells
(100 μg/ml) and in parallel with rPDHA-D (10 μg/ml). The recombinant protein rP12 con-
firmed as involved in cytoadherence acted as positive control [27]. Recombinant protein rP8
(part of middle region of the P1 protein) which was characterized as not able to bind to HeLa
cells was used as negative control [27]. Eluates obtained after processing lysed E. coli BL21
(DE3) cells through Ni-NTA-agarose columns were included to test the influence of remaining
E. coli proteins on binding to HeLa cells. After blocking, recombinant proteins rPDHA-D, rP8,
rP12 and E. coli-specific proteins (10 μg/ml) were added to cell-coated wells and incubated for
2 hours at 37°C. Simultaneously, wells with immobilized proteins were incubated with PBS
under the same experimental conditions. After washing, proteins in wells with and without
HeLa cells were detected with guinea pig sera to the six recombinant proteins and to the E. coli
proteins (1:1000) followed by peroxidase-labeled anti-guinea pig IgG (1:1000).
To test the influence of the antisera against the proteins of the PDH complex on the binding
to HeLa cells, wells of ELISA plates were coated with freshly harvested HeLa cells for 2 hours at
37°C (100 μg/ml). In parallel, recombinant proteins rPDHA-D (50 μg/ml) were pre-incubated
with the corresponding antisera (1:50 in PBS) for 1.5 hours at room temperature in an over-
head shaker. Recombinant protein GAPDH [22] was also treated with sera against the recom-
binant proteins PDHA-D to analyze cross-reactions of the sera with a non-corresponding
protein. Treated recombinant proteins rPDHA-D and rGAPDH were added to the human
cells and incubated for 2 hours at 37°C. After washing, bound recombinant proteins were de-
tected by incubating the wells with the corresponding antisera (1:1000) and anti-guinea pig
IgG (1:1000).
Characterization of PDH Cluster ofMycoplasma pneumoniae
PLOSONE | DOI:10.1371/journal.pone.0126600 May 15, 2015 5 / 20
Adhesion inhibition assay
An ELISA-based assay was used to quantify the influence of the antisera to proteins of the
PDH complex on the adhesion ofM. pneumoniae to HeLa cells. ELISA plates were coated with
freshly harvested HeLa cells (100 μg/ml) for 2 hours at 37°C. Simultaneously, freshly grownM.
pneumoniae cells were prepared as described and resuspended in PBS to an OD660 of 0.44. The
suspension was sheared through a 27-gauge needle (B. Braun, Melsungen, Germany,
#9161627S) to reduce self-aggregation of bacteria. The mycoplasma suspension was diluted
1:20 in PBS containing 50% PPLO medium and 10% heat-inactivated antiserum to recombi-
nant proteins PDHA-D, to total antigen ofM. pneumoniae (positive control) or pre-immune
guinea pig serum (negative control). The mixtures were incubated for 1.5 hours at 37°C with
head-over-head rotation and added to the blocked wells of ELISA plates for 1.5 hours at 37°C
with mild shaking. After washing, bound bacteria were detected by incubating the wells with
the rabbit antiserum against the TX-100 insoluble fraction (1:500) and peroxidase-conjugated
anti-rabbit IgG (Dako, #P039901-2, 1:1000). Three independent experiments with eight paral-
lels each were carried out.
Binding of human plasminogen
The interaction of human plasminogen withM. pneumoniae proteins was analyzed as de-
scribed recently [21]. Briefly, after separation by SDS-PAGE, the recombinant proteins
rPDHA-D, total proteins ofM. pneumoniae and BSA (100 μg each) were blotted onto a nitro-
cellulose membrane. Human plasminogen (5 μg/ml, Sigma, #P7999) was added and incubated
for 2 hours at room temperature on a shaker. PBS was used as control. Following three washing
steps, the membranes were incubated with rabbit anti-plasminogen (1:3000, Sigma,
#HPA021602) for 2 hours at room temperature. Bound plasminogen was detected with peroxi-
dase-conjugated anti-rabbit IgG (1:1000).
Concentration-dependent binding of plasminogen to recombinant proteins was quantified
by ELISA [21]. Wells were coated with recombinant proteins rPDHA-D (10 μg/ml). Different
concentrations of plasminogen (0.1, 0.25, 0.5, 0.75, 1 and 5 μg/ml) and PBS were added for
2 hours at 37°C. Bound plasminogen was detected with anti-plasminogen (1:2000) and anti-
rabbit IgG (1:1000).
In addition, the influence of the corresponding antisera to subunits of the PDH complex on
binding of human plasminogen toM. pneumoniae cells and to the recombinant proteins
rPDHA-D was tested. Wells of ELISA plates were coated with the recombinant proteins
(15 μg/ml) or total proteins ofM. pneumoniae (25 μg/well). Increasing concentrations of plas-
minogen (0.25, 0.5, 1.0, 5 μg/ml) in PBS were incubated with antiserum against PDHA-D and
guinea pig pre-immune serum as control (1:100 each) for 1.5 hours at room temperature with
overhead rotation. The mixtures were added to immobilized antigens and incubated for
2 hours at 37°C. Bound plasminogen was detected with anti-plasminogen (1:500) and peroxi-
dase-conjugated anti-rabbit IgG (1:750) as described.
To analyze the role of ionic interactions in plasminogen binding [28], 96-well plates were
coated overnight with recombinant proteins rPDHA-D (10 μg/ml) at 4°C. After washing and
blocking, human plasminogen (10 μg/ml PBS) with increasing concentrations of NaCl (Roth,
#9265.2) or heparin (Sigma, #H3393) were added to bound proteins and incubated for 2 hours
at 37°C. Bovine serum albumin (BSA, Pierce, #23209) was used as negative control. Bound
plasminogen was detected using rabbit anti-plasminogen (1:500) and anti-rabbit IgG (1:750) as
described above.
To investigate the influence of lysine residues on plasminogen binding, the lysine analog ε-
aminocaproic acid (1mM, Sigma, #07260, [28]) and human plasminogen (10 μg/ml PBS) were
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added to rPDHA-D or BSA (10 μg/ml each) and immobilized in wells of an ELISA plate. As
control for a plasminogen-binding protein part that is insensitive to the lysine analog, peptide
3 of the panel of peptides overlapping PDHB was used [21]. Detection was carried out as
described above.
Plasminogen activation assay
The ability of subunits of PDH complex ofM. pneumoniae to activate plasminogen to plasmin
was monitored in a quantitative assay as described [29]. Briefly, wells of ELISA plates were
coated with recombinant proteins rPDHA-D or BSA as negative control (10 μg/ml each) and
blocked. Human plasminogen (10 μg/ml PBS) was added and incubated for 2 hours at 37°C.
After washing, human uPA (4 ng per well; Millipore, #CC400) and the plasmin-specific sub-
strate D-valyl-leucyl-lysine-p-nitroanilide dihydrochloride (0.4 mM; Sigma, #V0882) were
added. The plates were incubated overnight at 37°C and plasmin was detected at 405 nm.
Fibrinogen degradation assay
To analyze whether the proteins of the PDH complex are able to degrade fibrinogen, an assay
was performed as reported [30]. Recombinant proteins rPDHA-D, total proteins ofM. pneu-
moniae or BSA (10 μg/ml of each) were immobilized in wells of a 96-well plate as described.
Human plasminogen (10 μg/ml PBS) was added for 2 hours at 37°C. After washing, human
uPA (80 ng/ml) and human fibrinogen (20 μg/ml, plasminogen-depleted, Millipore, # 341578)
was incubated at room temperature. After different time points, aliquots were taken and the re-
action was stopped by heating for 10 minutes at 56°C. The heat-inactivated samples were used
to coat 96-well plates overnight at 4°C. After washing and blocking, the degradation of fibrino-
gen was analyzed using goat anti-fibrinogen (1:1000, Sigma, #F8512) for 90 minutes at room
temperature. Detection was carried out with peroxidase-conjugated anti-goat IgG (1:1000,
Sigma, #A4174).
Results
Production of recombinant proteins rPDHA-D ofM. pneumoniae and
generation of monospecific antisera
After exchanging the TGA codons in three of four genes, the complete genes encoding for sub-
units of the PDH complex were amplified and cloned into the pET-30 vector. The proteins
were expressed in E. coli, purified by affinity chromatography and separated by SDS-PAGE.
Coomassie staining of gels resulted in prominent products with the expected molecular weights
(Fig 1A). In addition, blotted recombinant proteins were detected with anti-His antibodies
confirming these prominent bands specifically (data not shown).
The recombinant proteins were used to produce polyclonal guinea pig antisera. The speci-
ficity was tested by incubation of sera to rPDHA-D with blotted totalM. pneumoniae proteins.
Exclusive signals were found at the predicted molecular weights of these proteins (Fig 1B). The
quantitative reactivity of anti-rPDHA-D in comparison to an antiserum to total proteins ofM.
pneumoniae was analyzed using an ELISA with immobilizedM. pneumoniae total proteins as
antigens. Comparable OD values regarding the sera to rPDHA, rPDHB and total proteins of
M. pneumoniae were found (Fig 1C). Sera to rPDHC and rPDHD showed significantly reduced
reactivity indicating a low density of epitopes, a lower affinity of antibodies and/or a low con-
centration of both antigens among totalM. pneumoniae proteins.
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Fig 1. Production and reaction of recombinant proteins rPDHA-D and corresponding polyclonal
guinea pig antisera. EK-LIC vector and E. coli BL21(DE3) were used to produce recombinant proteins. (A)
Proteins were purified, concentrated, separated by SDS-PAGE and stained with Coomassie. (B) Western
blot reaction of total proteins ofM. pneumoniaeM129 with antisera to rPDHA-D. (C) Results of ELISA
experiments to analyze the reactivity of antisera to total proteins and to PDH subunits A-D with whole antigen
ofM. pneumoniaeM129. Data represent means and standard deviations of eight parallels.
doi:10.1371/journal.pone.0126600.g001
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Localization of subunits of the PDH complex inM. pneumoniae cells
The ELISA reaction of the antibodies to recombinant proteins rPDHA-C with the membrane
and cytosolic protein fraction ofM. pneumoniae whole cells demonstrated the distribution of
these glycolytic enzymes in both compartments (Fig 2A). The cytosolic enzyme enolase and
the surface-exposed C-terminal part of the main P1 adhesin were used as controls for the ap-
propriate performance of the test. The results are confirmed by ELISA experiments using the
TX-100 soluble and TX-100 insoluble protein fractions [23] as well as the protein fractions ob-
tained after using the ProteoExtrakt Transmembrane Protein Extraction Kit (Merck) as anti-
gens (data not shown).
To prove the occurrence of glycolytic enzymes on the surface of mycoplasma cells, grown
bacteria were fixed and incubated with guinea pig sera to recombinant proteins rPDHA-C of
M. pneumoniae (Fig 2B). Surface-displayed proteins were detected by fluorescence microscopy
using FITC- and TRITC-labeled secondary antibodies against guinea pig and rabbit IgG.
Strong signals were obtained with sera against PDHA-C, whereas cells treated with sera to
PDHD and to enolase remained negative. Incubation with guinea pig pre-immune serum con-
firmed that unspecific cross-reactions are not assumed.
In colony blot experiments using 8-day-old agar cultures, antisera to PDHA-C and to total
proteins ofM. pneumoniae reacted strongly, but no signals were obtained using the serum to
PDHD (Fig 2C). The absence of reactivity of antiserum to enolase and of guinea pig pre-im-
mune serum indicates that detection of cytosolic proteins and nonspecific reactions
were excluded.
Incubation of trypsin-treated and blottedM. pneumoniae cells with antisera to recombinant
PDH subunits yielded partial degradation products of proteins PDHA-C (Fig 2D). In contrast,
PDHD was stable during these experimental conditions. The stability of the cytosolic glycolytic
enzyme enolase (negative control) indicates integrity of the cell membrane after trypsin treat-
ment whereas the C-terminal part of the P1 adhesin (positive control) was completely digested.
Digestion of recombinant proteins enolase and PDHD confirmed cleavability of these proteins.
Further experiments demonstrated thatM. pneumoniae colonies treated with trypsin showed a
decrease of PDHA-C-positive colonies of 30% in comparison to untreated colonies (data not
shown).
Taking the results of localization experiments together, all four PDH subunits can be found
in both fractions of membrane-associated and cytosolic proteins ofM. pneumoniae. Further-
more, PDHA-C occur in high concentrations on the surface of mycoplasma cell whereas
PDHD does not.
Interaction of HeLa cells and human plasminogen with recombinant
PDHA-D
To demonstrate the potential binding, HeLa cells were incubated with rPDHA-D. Bound re-
combinant proteins were detected with the corresponding antisera (Fig 3A). The resulting OD
values were compared with the reaction of the antisera with immobilized recombinant proteins
of the same concentration. For the positive control rP12 and all four rPDHA-D subunits, high
binding to HeLa cells was demonstrated which exceeded the OD values obtained after incuba-
tion of recombinant proteins without cells with the corresponding antisera. Both negative con-
trols were not able to bind to HeLa cells. The interaction between HeLa cells and the
recombinant proteins was significantly reduced by pre-incubation of proteins with the corre-
sponding antisera in comparison to guinea pig pre-immune serum (Fig 3B). To confirm the
specific influence of sera on the interaction between rPDHA-D and human cells, recombinant
GAPDH ofM. pneumoniae was included, which was characterized as protein with strong
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Fig 2. Localization of PDHA-D inM. pneumoniae cells. (A) Reactivity of guinea pig anti-rPDHA-D (1:250) with immobilized membrane and cytosolic
proteins ofM. pneumoniaeM129. Sera to the surface-exposed C-terminal part of the main P1 adhesin (P12) and to cytosolic enolase (Eno) ofM.
pneumoniae acted as controls. Data showmeans and standard deviations of eight parallels. (B) Immunofluorescence of fixedM. pneumoniae cells treated
with a mixture of guinea pig anti-rPDHA-D and rabbit anti-TX-100 insoluble protein fraction (positive control). Mixture of rabbit anti-TX-100 insoluble protein
fraction and guinea pig anti-enolase as well as guinea pig pre-immune serum (PIS) act as negative controls. Detection was carried out by incubation with
FITC-conjugated anti-guinea pig IgG and TRITC-conjugated anti-rabbit IgG. Bar: 10 μm. (C) Immunoblot reaction of 8 days-oldM. pneumoniaeM129
colonies. Colonies were covered with nitrocellulose membrane followed by incubation with sera to recombinant proteins PDHA-D. The reaction of anti-PDHA
and anti-PDHD is illustrated as an example. Further positive signals were obtained after incubation of blots with anti-PDHB, anti- PDHC and the positive
control anti-rP12, respectively (data not shown). The control anti-enolase demonstrated a negative result. Bar: 200 μm. (D) Results of the trypsin treatment of
freshly grownM. pneumoniaeM129 cells. Harvested bacteria were treated with increasing concentrations of trypsin or PBS as control. The reaction was
stopped by boiling, samples were separated by SDS-PAGE and blotted. Nitrocellulose membranes were incubated with sera to cytosolic enolase (negative
control), the surface-exposed near C-terminal part of adhesin P1 (P12; positive control) and to recombinant PDHA-D, respectively. Treatment of recombinant
proteins enolase and PDHDwith trypsin was used to confirm digestibility.
doi:10.1371/journal.pone.0126600.g002
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Fig 3. Binding of recombinant proteins rPDHA-D to human cells. (A) ELISA results after incubation of
recombinant proteins with immobilized HeLa cells and detection with antisera to PDHA-D. OD values were
compared with wells coated with recombinant proteins. Recombinant protein rP8 (middle part of the P1
protein without interaction to human cells) and remaining E. coli-specific proteins after Ni-agarose affinity
chromatography (BL21(DE3)) acted as controls. The C-terminal part of the P1 protein (rP12) was used as
positive control. Data represent means and standard deviations of eight parallels. (B) Influence of sera
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binding to HeLa cells [22]. Using the sera to subunits of the PDH complex, an influence on the
association of GAPDH to cells was missing (data not shown). However, pre-incubation ofM.
pneumoniae with single and pooled monospecific antisera to the PDH subunits had no mea-
surable influence on the binding ofM. pneumoniae to HeLa cells and is in accordance with the
results of the antiserum to cytosolic protein enolase (Fig 3C). In contrast, pre-incubation of
bacteria with antiserum to total proteins ofM. pneumoniae reduced the adherence of
mycoplasmas significantly.
Testing the ability of separated total proteins ofM. pneumoniae to bind human ECM pro-
teins in a ligand immunoblot assay resulted in three bands after incubation with plasminogen
(Fig 4A). Comparison of the molecular weight of binding partners inM. pneumoniae indicated
an association of plasminogen with PDH subunits A and/or C (40.6 and 42.4 kDa) and B (35.9
kDa). Using recombinant proteins in the immunoblot, interaction of plasminogen and all four
rPDH subunits is assumed (Fig 4A). This means that at least a further plasminogen-binding
protein inM. pneumoniae can be expected (around 60 kDa). In addition, the interaction of re-
combinant protein PDHD with plasminogen is not confirmed by the investigation of whole
mycoplasma cells probably caused by a low concentration and/or the particular association of
the protein with components of the membrane. No signal was obtained after treatment of nega-
tive control BSA. Additional ELISA experiments showed concentration-depending binding of
plasminogen to PDH subunits (Fig 4B). In comparison with guinea pig pre-immune serum,
pre-incubation of human plasminogen with antisera to PDHA-D reduced the binding between
plasminogen and recombinant proteins used as antigens in ELISA experiments significantly
(Fig 4C). In addition, treatment with pooled antisera to PDHA-C decreased the association of
M. pneumoniae cells to immobilized plasminogen concentrations> 0.5 μg/ml (Fig 4D). In con-
trast, pre-incubation of bacteria with the antiserum to total proteins ofM. pneumoniae resulted
in binding to plasminogen corresponding quantitatively to cells treated with pre-immune
serum (data not shown).
Characterization of binding of the PDH subunits to human plasminogen
and of plasminogen activation
To characterize the binding of PDH subunits to plasminogen and the possible role in patho-
genesis, the influence of ionic interactions, lysine residues and the activation of human plas-
minogen to plasmin were analyzed. Because of the high number of charged amino acids in the
PDH subunits, binding assays in the presence of different concentrations of NaCl were carried
out to analyze the role of ionic interactions in the association of human plasminogen with re-
combinant proteins PDHA-D. These experiments showed absence of an effect of NaCl regard-
ing the binding of subunits B and D (Fig 5A). Comparable assays using heparin in increasing
concentrations led to similar results (data not shown). In contrast, the presence of various con-
centrations of NaCl and heparin reduces binding between human plasminogen and rPDHA
and C significantly. Many bacterial proteins may contain lysine residues (subunits of PDH
complex: 8 to 10%) and kringle domains of plasminogen are able to bind such residues [31]. In
against recombinant proteins on binding of rPDHA-D to HeLa cells. rPDHA-D were pre-incubated with
antisera to PDHA-D and added to immobilized HeLa cells. Incubation of recombinant proteins with guinea pig
pre-immune serum was used as control. Data represent means and standard deviations of eight parallels
(*** = P<0.001; student’s t-test). (C) Results of adhesion inhibition assay. Wells of ELISA plates were coated
with HeLa cells.M. pneumoniae cells were pre-incubated with different antisera and added to immobilized
human cells. Detection of bound mycoplasmas was carried out with rabbit antiserum to the fraction of TX-100
insoluble proteins ofM. pneumoniae. Means and standard deviations of three independent experiments with
eight parallels each are shown (*** = P<0.001; student’s t-test).
doi:10.1371/journal.pone.0126600.g003
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Fig 4. Binding of human plasminogen (plg) to recombinant proteins rPDHA-D. (A) Western blot analysis of immobilized total proteins ofM. pneumoniae
M129 and recombinant proteins rPDHA-D incubated with human plasminogen. Bound plasminogen was detected with rabbit anti-plasminogen and anti-
rabbit IgG. Treatment of blotted BSA (66.5 kDa) served as negative control. (B) ELISA experiments to characterize the binding of different concentrations of
plasminogen to immobilized rPDHA-D. Detection of plasminogen was carried out as described. Data represent means and standard deviations of eight
parallels. (C) Influence of pre-incubation of rPDHA-D with the corresponding antisera on the interaction of human plasminogen with recombinant proteins.
Plasminogen was pre-incubated with the sera against the subunits and added to immobilized recombinant proteins. Detection of bound plasminogen in
comparison with controls using pre-immune serum (PIS) for pre-incubation was carried out by using anti-plasminogen and peroxidase-conjugated anti-rabbit
IgG. Data represent means and standard deviations of eight parallels (*** = P<0.001; student’s t-test). (D) Concentration-dependent binding of plasminogen
pre-incubated with the antiserum to whole proteins and with the mixture of anti-rPDHA-D to immobilized total proteins ofM. pneumoniaeM129 (M.p.).
Plasminogen incubated with guinea pig pre-immune serum (PIS) was used as control. Means and standard deviations of eight parallels are shown (** =
P<0.01; student’s t-test).
doi:10.1371/journal.pone.0126600.g004
Characterization of PDH Cluster ofMycoplasma pneumoniae
PLOSONE | DOI:10.1371/journal.pone.0126600 May 15, 2015 13 / 20
an ELISA experiment, the addition of the lysine analog ε-aminocaproic acid reduces (between
27% and 48%) the plasminogen binding to all PDH subunits significantly (Fig 5B), indicating
the important role of lysine in these interactions. The interaction of peptide 3 (91FPAMF-
QIFTHAA102) derived from PDHB ofM. pneumoniae was not influenced by ε-
aminocaproic acid.
In the presence of an adequate activator, human plasminogen can be activated to plasmin,
thus influencing the coagulation cascade. To determine the potential of rPDHA to D to activate
plasminogen, recombinant proteins were consecutively incubated with human plasminogen,
uPa and a plasmin-specific chromogenic substrate. Only subunit B of the PDH complex serves
as activator (Fig 6A). As expected, the addition of ε-aminocaproic acid also reduced plasmino-
gen activation (data not shown). To determine if the plasmin formation by the activator
rPDHB is able to degrade the natural substrate fibrinogen, recombinant protein was immobi-
lized to 96-well plates and incubated with plasminogen, uPA and fibrinogen. In comparison to
BSA as control protein without the ability to activate plasminogen, degradation of fibrinogen
by the plasminogen-rPDHB complex was confirmed (Fig 6B).
Discussion
Surface localization is a precondition for proteins of pathogenic micro-organisms to perform
important steps in host colonization such as adhesion, dissemination in tissues or immune
modulation. In the present study we showed that different glycolytic enzymes of the PDH com-
plex of a common pathogen of human respiratory tract infections are surface displayed and in-
teract with host factors. Interaction between different proteins of bacteria, fungi and parasites
Fig 5. Characterization of interaction between human plasminogen and rPDHA-D. (A) The role of ionic interactions was analyzed using an ELISA
assay. Recombinant proteins were immobilized to 96-well plates. Plasminogen was incubated with PBS and different concentrations of NaCl and added to
the wells. Bound plasminogen was detected using rabbit anti-plasminogen. Data represent means and standard deviations of eight parallels (*** = P<0.001;
student’s t-test). (B) To investigate the role of lysine, wells coated with rPDHA-D were incubated with human plasminogen in the presence of ε-aminocaproic
acid (ACA). Peptide FPAMFQIFTHAA (PDHB-P3, [21]) served as negative control. Bound plasminogen was detected as described. Data represent means
and standard deviations of eight parallels (** = P<0.01, *** = P<0.001; student’s t-test).
doi:10.1371/journal.pone.0126600.g005
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and various ECM proteins is described in a multitude of studies [12]. Nevertheless, proteins
with moonlighting function are of special interest in species of the classMollicutes with strong-
ly reduced genomes and therefore only a small repertoire of factors allowing their survival and
proliferation in their hosts. In this context, the dual role of proteins with functions in
Fig 6. Activation of human plasminogen in the presence of rPDHA-C and degradation of fibrinogen. (A) Plasminogen bound to rPDHB is converted
into plasmin. Wells of ELISA plates were coated with rPDHA-D and incubated with plasminogen. Urokinase (uPA) and plasmin-specific substrate (D-Val-
Leu-Lys-p-nitroanilide dihydrochloride; S) were added and incubated overnight. The activity of plasmin was detected by measuring the absorbance at 405
nm. BSA acted as control. Means and standard deviations of eight parallels (** = P<0.01; student’s t-test). (B) Human fibrinogen is degraded by rPDHB.
Recombinant protein rPDHB and BSA as control were immobilized in wells of ELISA plates and incubated with plasminogen. After washing, uPa and
fibrinogen were added. Samples were taken at different time points up to 2 hours. Degradation products were determined using goat anti-fibrinogen and
polyclonal peroxidase-conjugated anti-goat IgG. Data represent means and standard deviations of eight parallels (* = P<0.05; student’s t-test).
doi:10.1371/journal.pone.0126600.g006
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metabolism and virulence is a way to compensate limited genetic resources. Interactions of gly-
colytic enzymes with host factors have been reported forMycoplasma gallisepticum [15],Myco-
plasma suis [16, 17],Mycoplasma bovis [18],Mycoplasma fermentans [19], andM.
pneumoniae, respectively. In the latter, an association of the surface-localized PDHB with
human fibronectin [20] as well as with plasminogen [21] was described. In addition, GAPDH
ofM. pneumoniae was characterized as a binding partner of human fibrinogen [22]. The find-
ings of our study extended the spectrum of surface-localized glycolytic enzymes not only in
mycoplasma species. To our knowledge, PDH subunits are not among glycolytic enzymes fre-
quently described on the surface of bacterial species, such as enolase or GAPDH. However,
PDHA-C were also detected among theM. bovis proteins inducing antibodies in naturally in-
fected animals [32]. Recently, the E1 beta-subunit of PDH (PDHB) was found surface-
expressed in Lactobacillus plantarum and also binds human fibronectin [33]. Summarizing the
available data, a network of associations between glycolytic enzymes ofM. pneumoniae and
host factors can be assumed. This includes the fact that the same glycolytic enzyme (PDHB) on
the cell surface is able to interact with different host proteins and also that different proteins of
the bacterium bind to human plasminogen.
The results of our study confirmed that the particular PDH subunits ofM. pneumoniae
show different characteristics. All of them are transported from the cytosol to the membrane
but only PDHA-C are surface-located. As typical for surface-exposed glycolytic enzymes, pre-
dicted signal sequences or membrane spanning motifs are also missing in the four subunits of
the PDH complex ofM. pneumoniae. In addition, the results of immunofluorescence experi-
ments confirmed that the subunits of the PDH complex ofM. pneumoniae were not trans-
ported to the surface of transformed E. coli BL21(DE3) cells during expression (data not
shown). This indicated an unknown species-specific transport mechanism of PDH subunits to
the cell surface. All proteins of the PDH complex are phosphorylated like many other enzymes
in glycolysis [34] encouraging the regulation of activity and localization. Interestingly, data
demonstrate that PDH subunits have limited surface accessibility. Treatment of intactM. pneu-
moniae cells with trypsin resulted in digestion products as well as the detection of undigested
proteins PDHA-C. It can be hypothesized that glycolytic enzymes are integrated into the cell
membrane of mycoplasmas exposing limited regions for interacting with host factors. This is
supported by the findings of a recent study confirming a short 12 amino acid part of PDHB
that is involved in plasminogen binding [21]. Probably because of the special tip structure with
defined adhesins, pre-incubation ofM. pneumoniae cells with the corresponding antisera to
PDH subunits had no influence on the adherence of bacteria to HeLa cells displaying high con-
centrations of plasminogen, fibrinogen and fibronectin on their surface. The data are in accor-
dance with results of previous studies indicating that the surface-displayed glycolytic enzymes
do not take part in the primary adhesion process [21, 22]. Thus, the surface exposure of the
proteins might have an impact in later phases of infection and colonization.
Plasminogen was characterized as the binding partner of various microbial proteins includ-
ing glycolytic enzymes in phylogenetically different micro-organisms, suggesting a general role
in the interaction with the host [35–37]. The occurrence of different glycolytic enzymes
(PDHA-D or enolase [21]) with plasminogen-binding properties inM. pneumoniae emphasize
the importance of this interaction. Human plasminogen is a 92 kDa serum protein and is the
inactive form of the proteolytic active plasmin, which plays a key role in dissolving fibrin clots
and degrades other coagulation proteins in the process of fibrinolysis [38, 39]. Here, it was
shown that the four subunits of the PDH complex are able to bind to human plasminogen.
Moreover, in the presence of the activator urokinase, subunit rPDHB ofM. pneumoniae acti-
vates plasminogen to plasmin and the converted plasmin degrades natural substrates like fi-
brinogen [36]. It was hypothesized that the formation and function of plasmin will promote
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the dissemination of microbes across host tissue barriers and/or will optimize supplying them
with nutrients. Binding of plasminogen is based on five kringle domains and these loop struc-
tures are stabilized by disulfide bonds [31]. The conformational changes after binding of lysine
residues activates plasminogen to plasmin, which is found for many proteins containing lysine
that serve as plasminogen binding partners in different organisms [40, 41]. The interaction be-
tween recombinant PDH subunits ofM. pneumoniae and human plasminogen was character-
ized by addition of anions. An effect was missing in the case of PDHA, PDHB and PDHD,
supporting the presumption that non-charged amino acids and conformations of the proteins
rPDHA, rPDHB and rPDHD are important for interaction. In contrast, the addition of anions
influenced the binding of PDHC to human plasminogen. Additionally, PDH subunit A and C
has no C-terminal lysine. This confirmed the study of Crowe et al. [42] demonstrating that
proteins without C-terminal lysine are able to bind plasminogen. Further, lysine residues
bound by kringle domains mediate association with fibrinogen and other ECM proteins [43].
This binding characteristic was analyzed by the addition of ε-aminocaproic acid to the binding
mixture. The substance has a high affinity to the kringle 1, kringle 4 and kringle 5 domains, but
shows weak association to kringle 2 and no affinity to the kringle 3 domain [44, 45]. The pres-
ence of ε-aminocaproic acid during binding of recombinant proteins PDH to plasminogen re-
duced the concentration of bound plasminogen but confirmed as well that several kringle
domains play a role in the interaction of the PDH subunits with human plasminogen. The
broad reactivity of the kringle domains of plasminogen might explain how different glycolytic
enzymes in a bacterium with limited protein resources are able to interact with human plas-
minogen. In contrast to other species that interact with plasminogen, e.g. Leptospira spp. [46],
humans are the only host ofM. pneumoniae in which the respiratory mucosa is infected exclu-
sively. Thus, the data confirmed the occurrence of different microbial plasminogen binding
partners despite a limited spectrum of receptors and binding sites in the naturally colonized
host organisms.
Conclusions
This is the first investigation of the localization of the subunits of a microbial PDH complex.
The PDH subunits of the clinically relevant speciesM. pneumoniae can be found in the cytosol
and in the fraction of membrane-associated proteins. In contrast to PDHA-C, PDHD does not
appear to be surface-located. The derived recombinant proteins PDHA-D are able to bind spe-
cifically to human plasminogen. The results support the concept of moonlighting proteins with
a dual role in metabolism and in virulence manifesting here as interaction with human plas-
minogen. The confirmation of a cluster of surface-displayed enzymes of a closely related part
of glycolysis is a new aspect not only in the biology of micro-organisms with minimal genome.
The results are of importance for the understanding of the human respiratory epithelium colo-
nization process byM. pneumoniae.
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